This Week in JAMA | GenomeWeb

This Week in JAMA

Premium

The Women’s Health Initiative study of estrogen therapy in women with hysterectomies was stopped early in 2004 due to an increased risk of stroke, and in a new study published this week in JAMA, researchers from the WHI report on the long-term health outcomes of the women in that study after stopping therapy. The women in the double-blind, placebo-controlled, randomized clinical trial received either conjugated equine estrogens or placebo for a median of 5.9 years, and then were followed for a mean of 10.7 years.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.